AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JUN 6 - (NewsRx.com & NewsRx.net) --
Preliminary research suggests that injecting the mumps vaccine at the tumor site can induce remission in more than 75% of children affected with recurrent respiratory papilloma (RRP), a disease of the upper airway caused by human papillomavirus (HPV).
Although benign, RRP tumors can reappear at regular intervals causing difficulties in breathing and speech, or in cases of lung involvement, death. Treatment for recurrent respiratory papilloma includes vigilant surveillance, repeated surgeries for removal of recurring tumors, and tracheostomy.
RRP is a relatively rare disease with severe and expensive consequences. Experts estimate that more than 40 million dollars are spent annually on treatments for the roughly 500 American children affected each year.
Nigel R.T. Pashley, MB, BS, FRCS(C) of Presbyterian/St. Luke's Hospital in Denver, Colorado, is the author of the pilot study indicating the effectiveness of using an inexpensive and safe mumps vaccine as a method of inducing remission in children with RRP. The results of his study were presented May 10, 2001, at the 16th Annual Meeting of the American Society of Pediatric Otolaryngology in Scottsdale, Arizona.
The study, involving 11 patients, was undertaken involving children age 18 months to eight years. After laser excision of each tumor, 2 ml of reconstituted mumps vaccine was injected at the base of the excision site using microscopic control and laryngeal injection ...
Source: HighBeam Research, Mumps Vaccine Causes Remission Of Human Papillomavirus-Caused...